Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder
Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder PR Newswire OSAKA, Japan and COPENHAGEN, Denmark, Sept. 30, 2013 OSAKA, Japan and COPENHAGEN, Denmark , Sept. 30, 2013 /PRNewswire/ — Takeda Pharmaceutical Company Limited (Takeda) and H […]